![]() |
|
|
Vol. 289, Issue 3, 1592-1599, June 1999
Division of Drug Delivery and Disposition, School of Pharmacy,
University of North Carolina, Chapel Hill, North Carolina
Previous work in our laboratory has indicated that biliary excretion of
a substrate in sandwich-cultured hepatocytes can be quantitated by
measurement of substrate accumulation in the presence and absence of
extracellular Ca2+. The present study was designed to
examine the effects of Ca2+ on taurocholate accumulation
and tight junction integrity in cultured hepatocytes. Kinetic modeling
was used to characterize taurocholate disposition in the hepatocyte
monolayers in the presence and absence of extracellular
Ca2+. The accumulation of taurocholate in freshly isolated
hepatocytes, which lack an intact canalicular network, was the same in
the presence and absence of extracellular Ca2+. Electron
microscopy studies showed that Ca2+ depletion increased the
permeability of the tight junctions to ruthenium red, demonstrating
that tight junctions were the major diffusional barrier between the
canalicular lumen and the extracellular space. Cell morphology and
substrate accumulation studies in the monolayers indicated that
Ca2+ depletion disrupted the tight junctions in 1 to 2 min.
The integrity of the disrupted tight junctions was not re-established
completely after reincubation in the presence of Ca2+ for
1 h. The accumulation of taurocholate was described best by a
two-compartment model (cytosol and bile) with Michaelis-Menten kinetics
for both uptake and biliary excretion. In summary, Ca2+
depletion does not alter hepatocyte transport properties of
taurocholate. Ca2+ modulation may be a useful approach to
study biliary excretion of substrates in sandwich-cultured hepatocytes.
This article has been cited by other articles:
![]() |
K. Abe, A. S. Bridges, and K. L. R. Brouwer Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors Drug Metab. Dispos., March 1, 2009; 37(3): 447 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abe, A. S. Bridges, W. Yue, and K. L. R. Brouwer In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes: Comparison with in Vivo Biliary Clearance J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 983 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukuda, R. Ohashi, M. Tsuda-Tsukimoto, and I. Tamai Effect of Plasma Protein Binding on in Vitro-in Vivo Correlation of Biliary Excretion of Drugs Evaluated by Sandwich-Cultured Rat Hepatocytes Drug Metab. Dispos., July 1, 2008; 36(7): 1275 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, P. B. Watkins, R. B. Kim, and K. L. R. Brouwer Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Bi, D. Kazolias, and D. B. Duignan Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport Drug Metab. Dispos., September 1, 2006; 34(9): 1658 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Turncliff, K. A. Hoffmaster, J. C. Kalvass, G. M. Pollack, and K. L. R. Brouwer Hepatobiliary Disposition of a Drug/Metabolite Pair: Comprehensive Pharmacokinetic Modeling in Sandwich-Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 881 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lengyel, Z. Veres, P. Szabo, L. Vereczkey, and K. Jemnitz CANALICULAR AND SINUSOIDAL DISPOSITION OF BILIRUBIN MONO- AND DIGLUCURONIDES IN SANDWICH-CULTURED HUMAN AND RAT PRIMARY HEPATOCYTES Drug Metab. Dispos., September 1, 2005; 33(9): 1355 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, B. J. Smith, C. Chen, E. Callegari, S. L. Becker, X. Chen, J. Cianfrogna, A. C. Doran, S. D. Doran, J. P. Gibbs, et al. Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1254 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, X. Tian, P. Chandra, and K. L. R. Brouwer Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes Mol. Pharmacol., April 1, 2005; 67(4): 1334 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hoffmaster, M. J. Zamek-Gliszczynski, G. M. Pollack, and K. L. R. Brouwer MULTIPLE TRANSPORT SYSTEMS MEDIATE THE HEPATIC UPTAKE AND BILIARY EXCRETION OF THE METABOLICALLY STABLE OPIOID PEPTIDE [D-PENICILLAMINE2,5]ENKEPHALIN Drug Metab. Dispos., February 1, 2005; 33(2): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tian, M. J. Zamek-Gliszczynski, P. Zhang, and K. L. R. Brouwer Modulation of Multidrug Resistance-Associated Protein 2 (Mrp2) and Mrp3 Expression and Function with Small Interfering RNA in Sandwich-Cultured Rat Hepatocytes Mol. Pharmacol., October 1, 2004; 66(4): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kostrubsky, S. C. Strom, J. Hanson, E. Urda, K. Rose, J. Burliegh, P. Zocharski, H. Cai, J. F. Sinclair, and J. Sahi Evaluation of Hepatotoxic Potential of Drugs by Inhibition of Bile-Acid Transport in Cultured Primary Human Hepatocytes and Intact Rats Toxicol. Sci., November 1, 2003; 76(1): 220 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Zamek-Gliszczynski, H. Xiong, N. J. Patel, R. Z. Turncliff, G. M. Pollack, and K. L. R. Brouwer Pharmacokinetics of 5 (and 6)-Carboxy-2',7'-Dichlorofluorescein and Its Diacetate Promoiety in the Liver J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 801 - 809. [Abstract] [Full Text] [PDF] |
||||